| Name | Title | Contact Details |
|---|
Developing high-value, global products for patients with significant unmet medical needs in niche indications
Kleo Pharmaceuticals is advancing the field of immunotherapy by developing small molecules that emulate biologics.
BLH provides precision load cells, weight and force measurement systems, strain gages, web tension transducers, and instrumentation
Vascular Therapies, Inc., a privately-held late-stage biopharmaceutical company, is developing the Sirolimus-eluting collagen implant for local, perivascular drug delivery.